Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Center for Women's Reproductive Health, The University of Alabama at Birmingham, Birmingham, Alabama.
Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Ochsner Health System, New Orleans, Louisiana.
Am J Perinatol. 2024 May;41(S 01):e641-e647. doi: 10.1055/a-1925-1134. Epub 2022 Aug 16.
A recent randomized controlled trial suggested that early gestational diabetes mellitus (GDM) screening in patients with obesity (body mass index [BMI] ≥30 kg/m) does not improve perinatal outcomes. The American College of Obstetrics and Gynecology currently recommends early screening for gestational diabetes in patients who are overweight with one or more additional risk factors. We evaluated the effect of screening based on the number of additional risk factors for development of gestational diabetes.
This was a secondary analysis of a multicenter randomized controlled trial of obese patients with singleton nonanomalous fetuses comparing early (14-20 weeks' gestation) with routine (24-28 weeks' gestation) GDM screening. Exclusion criteria were pregestational diabetes, major medical illnesses, bariatric surgery, chronic steroid use, and prior cesarean. Early versus routine GDM screening groups were compared and stratified by the number of additional risk factors for GDM (0, 1, 2, and ≥3). The primary outcome was an adverse perinatal composite outcome composed of: macrosomia, primary cesarean delivery, hypertensive disorders of pregnancy, shoulder dystocia, neonatal hyperbilirubinemia, and neonatal hypoglycemia. Analyses examined effects of early versus routine screening by the number of additional risk factors and their possible interaction on the incidences of the primary outcome and GDM.
Of 913 patients, 5% had 0, 52% had 1, 33% had 2, and 10% had ≥3 additional risk factors. Baseline characteristics, including the number and type of risk factors, were similar between early and routine screening groups. Breslow-Day test for interaction between early versus routine screening and the number of additional risk factors was not significant for either the primary outcome ( = 0.37) or the diagnosis of GDM ( = 0.28). The incidence of GDM and the adverse perinatal composite outcome increased as the number of risk factors increased ( < 0.001).
In patients with BMI ≥30 kg/m and additional risk factors, early GDM screening does not prevent adverse outcomes.
· The ACOG currently recommends early screening for gestational diabetes if patients have risk factors.. · Even in patients with multiple risk factors, early screening for GDM does not improve outcomes.. · Patients with three or more risk factors may have worse outcomes if they undergo early screening..
最近一项随机对照试验表明,对肥胖患者(体重指数 [BMI]≥30kg/m)进行早期妊娠糖尿病(GDM)筛查并不能改善围产期结局。美国妇产科医师学会目前建议对超重且有一个或多个其他危险因素的患者进行早期妊娠糖尿病筛查。我们评估了基于 GDM 发展的其他危险因素数量进行筛查的效果。
这是一项针对肥胖、单胎非畸形胎儿患者的多中心随机对照试验的二次分析,比较了早期(14-20 周妊娠)与常规(24-28 周妊娠)GDM 筛查。排除标准为孕前糖尿病、重大疾病、减重手术、长期使用类固醇和既往剖宫产。早期与常规 GDM 筛查组按 GDM 的其他危险因素数量(0、1、2 和≥3)进行比较和分层。主要结局是由巨大儿、初次剖宫产、妊娠高血压疾病、肩难产、新生儿高胆红素血症和新生儿低血糖组成的不良围产综合结局。分析检查了早期与常规筛查按其他危险因素数量的影响,及其对主要结局和 GDM 发生率的可能交互作用。
在 913 名患者中,5%的患者有 0 个,52%的患者有 1 个,33%的患者有 2 个,10%的患者有≥3 个其他危险因素。早期与常规筛查组的基线特征,包括危险因素的数量和类型,均相似。Breslow-Day 检验用于检验早期与常规筛查和其他危险因素数量之间的交互作用,对于主要结局(=0.37)和 GDM 的诊断(=0.28)均无统计学意义。随着危险因素数量的增加,GDM 的发生率和不良围产综合结局增加( < 0.001)。
在 BMI≥30kg/m 和有其他危险因素的患者中,早期 GDM 筛查并不能预防不良结局。
·ACOG 目前建议,如果患者有危险因素,应进行早期妊娠糖尿病筛查。·即使在有多个危险因素的患者中,早期 GDM 筛查也不能改善结局。·如果进行早期筛查,有三个或更多危险因素的患者可能会有更差的结局。